Abstract

Diabetic retinopathy is a common complication of long-term diabetes and that could lead to vision loss. Unfortunately, early diabetic retinopathy remains poorly understood. There is no effective way to prevent or treat early diabetic retinopathy until patients develop later stages of diabetic retinopathy. Elevated acellular capillary density is considered a reliable quantitative trait present in the early development of retinopathy. Hence, in this study, we interrogated whole retinal vascular transcriptomic changes via a Nile rat model to better understand the early pathogenesis of diabetic retinopathy. We uncovered the complexity of associations between acellular capillary density and the joint factors of blood glucose, diet, and sex, which was modeled through a Bayesian network. Using segmented regressions, we have identified different gene expression patterns and enriched Gene Ontology (GO) terms associated with acellular capillary density increasing. We developed a random forest regression model based on expression patterns of 14 genes to predict the acellular capillary density. Since acellular capillary density is a reliable quantitative trait in early diabetic retinopathy, and thus our model can be used as a transcriptomic clock to measure the severity of the progression of early retinopathy. We also identified NVP-TAE684, geldanamycin, and NVP-AUY922 as the top three potential drugs which can potentially attenuate the early DR. Although we need more in vivo studies in the future to support our re-purposed drugs, we have provided a data-driven approach to drug discovery.

Details

Title
Transcriptomic clock predicts vascular changes of prodromal diabetic retinopathy
Author
Toh, Huishi 1 ; Smolentsev, Alexander 1 ; Sadjadi, Ryan 1 ; Clegg, Dennis 2 ; Yan, Jingqi 3 ; Stewart, Ron 4 ; Thomson, James A. 5 ; Jiang, Peng 6 

 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676) 
 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California Santa Barbara, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676) 
 Cleveland State University, Department of Biological, Geological and Environmental Sciences, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Cleveland State University, Center for Gene Regulation in Health and Disease, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730) 
 Morgridge Institute For Research, Madison, USA (GRID:grid.509573.d) (ISNI:0000 0004 0405 0937) 
 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California Santa Barbara, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); Morgridge Institute For Research, Madison, USA (GRID:grid.509573.d) (ISNI:0000 0004 0405 0937) 
 Cleveland State University, Department of Biological, Geological and Environmental Sciences, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Cleveland State University, Center for Gene Regulation in Health and Disease, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Case Western Reserve University, Center for RNA Science and Therapeutics, School of Medicine, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847) 
Pages
12968
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2848620268
Copyright
© Springer Nature Limited 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.